Who owns Sutro Biopharma Inc?
- Ticker: STRO
- CUSIP Number: 869367102
Tip: Access positions for across all investors
Analyze quarterly positions in Sutro Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Sutro Biopharma stock
Who bought or sold Sutro Biopharma Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Suvretta Capital Management | 5.8M | $33M | -2% | Mar 2024 |
|
| BlackRock | 5.7M | $32M | -5% | Mar 2024 |
|
| Millennium Management | 4.7M | $27M | 208% | Mar 2024 |
|
| MPM Oncology Impact Management | 4.1M | $23M | 100% | Mar 2024 |
|
| Vanguard Group | 3.0M | $17M | 5% | Mar 2024 |
|
| Kynam Capital Management | 2.0M | $11M | 0% | Mar 2024 |
|
| Adage Capital Partners GP | 2.0M | $11M | -36% | Mar 2024 |
|
| Baillie Gifford & Co | 1.8M | $10M | -1% | Mar 2024 |
|
| Parkman Healthcare Partners | 1.8M | $10M | 51% | Mar 2024 |
|
| Samsara BioCapital | 1.7M | $9.5M | 0% | Mar 2024 |
|
| Dimensional Fund Advisors | 1.3M | $7.4M | 15% | Mar 2024 |
|
| Geode Capital Management | 1.3M | $7.3M | 7% | Mar 2024 |
|
| Acadian Asset Management | 1.2M | $6.8M | 56% | Mar 2024 |
|
| Aquilo Capital Management | 1.2M | $6.6M | 177% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 1.1M | $6.3M | 232% | Mar 2024 |
|
| Jacobs Levy Equity Management | 1.1M | $6.0M | 214% | Mar 2024 |
|
| Goldman Sachs Group | 803k | $4.5M | -24% | Mar 2024 |
|
| PanAgora Asset Management | 785k | $4.4M | 74% | Mar 2024 |
|
| Two Sigma Advisers | 671k | $3.8M | 180% | Mar 2024 |
|
| Morgan Stanley | 549k | $3.1M | 258% | Mar 2024 |
|
| Northern Trust | 486k | $2.7M | 0% | Mar 2024 |
|
| Two Sigma Investments | 486k | $2.7M | 50% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 440k | $2.5M | -51% | Mar 2024 |
|
| Citadel Advisors | 351k | $2.0M | 160% | Mar 2024 |
|
| Nuveen Asset Management | 338k | $1.9M | 59% | Mar 2024 |
|
| DAFNA Capital Management | 334k | $1.9M | 18% | Mar 2024 |
|
| Verition Fund Management | 284k | $1.6M | -89% | Mar 2024 |
|
| Bridgeway Capital Management | 276k | $1.6M | 100% | Mar 2024 |
|
| Point72 Asset Management | 261k | $1.5M | -9% | Mar 2024 |
|
| UBS O'Connor | 255k | $1.4M | 100% | Mar 2024 |
|
| D. E. Shaw & Co | 242k | $1.4M | 100% | Mar 2024 |
|
| Fisher Investments | 197k | $1.1M | 0% | Mar 2024 |
|
| Propel Bio Management | 195k | $1.1M | 0% | Mar 2024 |
|
| Tejara Capital | 194k | $1.1M | -14% | Mar 2024 |
|
| Cubist Systematic Strategies | 194k | $1.1M | 154% | Mar 2024 |
|
| Man Group | 191k | $1.1M | 60% | Mar 2024 |
|
| Bank of New York Mellon | 185k | $1.0M | -30% | Mar 2024 |
|
| Charles Schwab Investment Management | 161k | $909k | 0% | Mar 2024 |
|
| Ameriprise Financial | 149k | $842k | 41% | Mar 2024 |
|
| Susquehanna Fundamental Investments | 127k | $715k | 78% | Mar 2024 |
|
| Simplify Asset Management | 120k | $678k | 0% | Mar 2024 |
|
| FMR | 112k | $635k | 40% | Mar 2024 |
|
| Russell Investments | 112k | $633k | 193% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 98k | $555k | 500% | Mar 2024 |
|
| Ohio Pers | 97k | $546k | 56% | Mar 2024 |
|
| Rhumbline Advisers | 94k | $532k | 3% | Mar 2024 |
|
| XTX Topco | 89k | $502k | 335% | Mar 2024 |
|
| Engineers Gate Manager | 81k | $455k | 100% | Mar 2024 |
|
| Barclays | 80k | $450k | -40% | Mar 2024 |
|
| Alliancebernstein | 75k | $323k | 0% | Dec 2023 |
|
| Jane Street | 75k | $422k | -29% | Mar 2024 |
|
| American Century Companies | 74k | $416k | 98% | Mar 2024 |
|
| Exchange Traded Concepts | 71k | $402k | 98% | Mar 2024 |
|
| Standard Life Aberdeen | 69k | $392k | 0% | Mar 2024 |
|
| Lighthouse Investment Partners | 67k | $376k | 100% | Mar 2024 |
|
| UBS Group | 65k | $365k | 8% | Mar 2024 |
|
| Virtu Financial | 63k | $357k | 277% | Mar 2024 |
|
| Chase Investment Counsel Corp. | 58k | $326k | 100% | Mar 2024 |
|
| Bank of America Corporation | 57k | $324k | -48% | Mar 2024 |
|
| Hsbc Holdings | 52k | $224k | 89% | Dec 2023 |
|
| Susquehanna International | 50k | $283k | -58% | Mar 2024 |
|
| Jpmorgan Chase & Co | 49k | $275k | -26% | Mar 2024 |
|
| Mirae Asset Global Investments | 44k | $203k | 100% | Mar 2024 |
|
| Dynamic Technology Lab Private | 37k | $211k | 168% | Mar 2024 |
|
| AQR Capital Management | 36k | $202k | -57% | Mar 2024 |
|
| CornerCap Investment Counsel | 36k | $202k | 0% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 34k | $191k | 4% | Mar 2024 |
|
| Kennedy Capital Management | 31k | $175k | 4% | Mar 2024 |
|
| American International | 30k | $128k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 28k | $122k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 27k | $155k | 18% | Mar 2024 |
|
| Two Sigma Securities | 23k | $132k | 100% | Mar 2024 |
|
| Pathstone Holdings | 23k | $129k | 100% | Mar 2024 |
|
| SG Americas Securities | 21k | $120k | -48% | Mar 2024 |
|
| Ing Investment Management | 20k | $113k | -19% | Mar 2024 |
|
| Principal Financial Group | 19k | $105k | -6% | Mar 2024 |
|
| T. Rowe Price Associates | 18k | $102k | 25% | Mar 2024 |
|
| Us Bancorp | 17k | $96k | 100% | Mar 2024 |
|
| Deerfield Management Company | 17k | $96k | 100% | Mar 2024 |
|
| Vontobel Holding | 15k | $85k | -98% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 15k | $84k | 100% | Mar 2024 |
|
| New York State Common Retirement Fund | 13k | $76k | -2% | Mar 2024 |
|
| Diversified Trust Company | 13k | $74k | 16% | Mar 2024 |
|
| Florida State Board of Administration | 12k | $57k | -29% | Mar 2024 |
|
| Hrt Financial | 12k | $68k | 100% | Mar 2024 |
|
| Citigroup | 12k | $65k | 34% | Mar 2024 |
|
| ProShare Advisors | 11k | $62k | -7% | Mar 2024 |
|
| Springbok Capital Management | 11k | $61k | -43% | Mar 2024 |
|
| Advisor Group Holdings | 11k | $61k | 6% | Mar 2024 |
|
| NISA Investment Advisors | 8.8k | $50k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 6.1k | $35k | -54% | Mar 2024 |
|
| Summit Investment Advisors | 5.0k | $28k | 0% | Mar 2024 |
|
| Legal & General Group | 5.0k | $28k | 0% | Mar 2024 |
|
| Tower Research Capital | 4.6k | $26k | -69% | Mar 2024 |
|
| HighMark Wealth Management | 2.3k | $13k | 0% | Mar 2024 |
|
| Quantbot Technologies | 2.1k | $12k | 100% | Mar 2024 |
|
| Amalgamated Bank | 2.0k | $11k | -62% | Mar 2024 |
|
| Royal Bank of Canada | 1.4k | $0 | -92% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 1.1k | $4.7k | -63% | Dec 2023 |
|
| Simplex Trading | 1.1k | $6.0k | 469% | Mar 2024 |
|
| Cape Investment Advisory | 1.0k | $4.3k | 100% | Dec 2023 |
|
| AdvisorNet Financial | 500.00 | $2.8k | 100% | Mar 2024 |
|
| Bogart Wealth | 500.00 | $2.8k | 0% | Mar 2024 |
|
| Parallel Advisors | 465.00 | $2.6k | 0% | Mar 2024 |
|
| Zurcher Kantonalbank | 285.00 | $1.6k | 0% | Mar 2024 |
|
| Federated Investors | 223.00 | $957.004500 | -97% | Dec 2023 |
|
| Brian McDonald | 49.00 | $277.668300 | -82% | Mar 2024 |
|
| CWM | 47.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 13.00 | $73.000200 | 100% | Mar 2024 |
|
Who sold out of Sutro Biopharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BVF | Dec 2023 | 3.3M | $14M |
| Rubric Capital Management | Sep 2023 | 3.3M | $12M |
| Franklin Resources | Dec 2023 | 2.8M | $12M |
| Pentwater Capital Management | Dec 2023 | 450k | $1.9M |
| Opaleye Management | Dec 2023 | 302k | $1.3M |
| Exome Asset Management | Dec 2023 | 154k | $659k |
| Walleye Trading Advisors | Dec 2023 | 73k | $314k |
| State of Wisconsin Investment Board | Dec 2023 | 30k | $130k |
| Trexquant Investment | Sep 2023 | 20k | $71k |
| Squarepoint Ops | Dec 2023 | 14k | $60k |
| Qube Research & Technologies | Sep 2023 | 5.0k | $17k |
| RidgeWorth Capital Management | Dec 2023 | 4.4k | $19k |
| Point72 Middle East FZE | Dec 2023 | 1.8k | $7.7k |
| Washington Trust Advisors | Dec 2023 | 179.00 | $767.999500 |